SEC Form 4 · accession 0001179110-16-017729
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas G Frinzi
Officer — Senior Vice President
Period of report
Jan 11, 2016
Accepted (ET)
Jan 13, 2016 · 5:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par valueF1 | Jan 11, 2016 | A | 12,000 | $0.00 | A | 12,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares represent a retention restricted stock award under the Abbott Laboratories 2009 Incentive Stock Program. The award generally vests on the third anniversary of its grant date and includes the right to have shares withheld for tax purposes.